Weekend Warriors

[PennyStock Alert]

Please DD Silicon Valley biotech, Arrayit Corporation ($ARYC) today. Many new updates last week on Twitter @Arrayit

Currently at .0054 and it is so unbelievably undervalued!!!!!

Arrayit reports $35,000 microarray services sale to a leading research laboratory specializing in complex pathways
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit new 3/23/2017 company newsletter features serum separation blood card tech for clinical microarray research
(link: http://arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html)
arrayit.com/Microarray_Dia…

Arrayit reports $100,000+ microarray services sale to a leading US-based research laboratory
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…

Arrayit reports partnership opportunity with $655MM healthcare manufacturing leader Quidel Nasdaq:QDEL San Diego CA
(link: http://www.quidel.com/spg)
quidel.com/spg

Arrayit Corporation provides $10MM funding proposal to top middle market merchant bank Aleutian Capital
http://www.
aleutiancapital.com

?pic.twitter.com/0FGHPyYkO9?

@Arrayit on Twitter

A list of Arrayit Corporation patents:

https://t.co/EMXlE743rz

Arrayit microarray platform used by customers at University Medicine Bethesda MD to publish cancer research advance

www.twitter.com/arrayit

WWW.Arrayit.com
Arrayit production team expands blood card manufacturing to 10,000 units per week to meet microarray research demand
http://
arrayit.com/Products/Prote
in_Microarrays/Blood_Card/blood_card.html
…
Arrayit anticipates significant participation in new congressional proposal for $4.8 billion 21st Century Cures Act
https://www.
genomeweb.com/policy-legisla
tion/congressional-committees-release-final-draft-21st-century-cures-act
…

Arrayit customers at Axo Science Lyon France use Arrayit microarray platform to ID bladder cancer prevention markers
http://
arrayit.com/Publications/b
ladder-cancer-prevention.pdf
…
Arrayit reports microarray technology sale to top nanotechnology healthcare leader Sonanutech Davis CA
http://
sonanutech.net

Arrayit reports microarray technology sale to world diagnostics leader Ventana Medical Sysytems Roche Tucson AZ
http://www.
ventana.com

Arrayit contact top Wells Fargo analyst Tim Evans explains revenue/earnings synergies in life science & diagnostics
http://
arrayit.com/Wells-Fargo-16
1114.pdf
…

Arrayit ships $35K proprietary microarray platform to leading European distributor Grupo Taper Mem Martins Portugal
http://www.
taper.es

Arrayit reports microarray technology sale to agricultural biotechnology leader Microgaia Biotech Murcia Spain
http://
microgaia.eu

Arrayit reports $100K microarray technology sale to world proteomics leader CDI Laboratories located in Baltimore MD
http://
cdi-lab.com

Arrayit featured in Global DNA Microarray Market Research Report 2016 with top molecular DX companies GE and Cepheid
http://www.
reportsnreports.com/reports/732130
-global-dna-microarray-market-research-report-2016.html
…

Arrayit designs custom microarray technology platform for top wellness testing company located in the European Union
http://
arrayit.com/Products/Micro
array_Platforms/microarray_platforms.html
…

Arrayit customers at the Korea Research Institute use the Arrayit microarray platform to publish biosensors advance
http://
pubs.acs.org/doi/abs/10.102
1/acs.analchem.6b02071
…

Arrayit confirms site visit business development meeting with advanced genomics leader Genomic Vision Bagneux France
http://www.
genomicvision.com

Arrayit SpotBot® Extreme Microarray Spotter newsletter receives 3,265 hits on life sciences tools segment strength
http://
arrayit.com/Products/Micro
arrayers/Microarray_Spotter/microarray_spotter.html
…

Arrayit reports $200,000 microarray platform inquiry from top life sciences leaders AH Diagnostics Aarhus Denmark
http://www.
ahdiagnostics.dk

Arrayit reports $34K microarray instrument sale to top European Union life sciences distributor European Biotech Network Dolembreux Belgium.

Arrayit equity research contact Tim Evans Wells Fargo illustrates 15-quarter strength of venture capital investing in biotechnology sector.